Shanghai HeartCare Medical Technology Corporation Limited (06609) disclosed a repurchase of 3,000 H shares on October 20, 2025, at HKD 55.35 per share, totaling HKD 166,050. These shares transitioned into treasury shares, raising the company’s treasury holdings of H shares from 513,750 to 516,750.
As of October 20, 2025, the number of issued H shares (excluding treasury shares) stands at 31,049,054, with the unlisted shares remaining at 7,268,604. The total issued H shares and unlisted shares at the time of the special resolution was 38,834,408 shares, comprising 31,565,804 H shares and 7,268,604 unlisted shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.